Principal TechnologiesTSXV:PTEC 22 EBITDA Margin % is 0.00% as of Jan. 2026. GuruFocus rates TSXV:PTEC with a GF Score™ of 22/100 and a GF Value™ of C$0.03 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Principal Technologies ranks worse than 98.05% on this metric.
Principal Technologies (TSXV:PTEC) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Principal Technologies EBITDA Margin % Related Terms
Principal Technologies EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Principal Technologies's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSXV:PTEC vs VEEV, BTSG, TEM: EBITDA Margin % Comparison
For the Health Information Services subindustry, Principal Technologies's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Principal Technologies EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Principal Technologies's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Principal Technologies's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Principal Technologies (TSXV:PTEC) has a EBITDA Margin % of 0.00% as of Jan. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Principal Technologies and its competitors. According to the industry distribution chart, Principal Technologies ranks #655 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 98.1%.
Is Principal Technologies' EBITDA Margin % too high?
Principal Technologies' current EBITDA Margin % is 0.00%. Based on the distribution chart, Principal Technologies ranks #655 out of 668 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Principal Technologies has a GF Score™ of 22/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Principal Technologies' EBITDA Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Principal Technologies ranks #655 out of 668 companies for EBITDA Margin %. This places Principal Technologies in the lower half of its industry. The industry median EBITDA Margin % is 10.21. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Principal Technologies and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Principal Technologies's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Principal Technologies stock overvalued right now?
Based on GuruFocus' analysis, Principal Technologies (TSXV:PTEC) is currently considered Significantly Overvalued. The stock's GF Value™ is C$0.03, compared to a current price of C$0.38 — trading 1166.7% above its estimated fair value. The current EBITDA Margin % is 0.00%. Principal Technologies' overall GF Score™ is 22/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Principal Technologies (TSXV:PTEC), the current EBITDA Margin % is 0.00% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Principal Technologies (TSXV:PTEC) Overvalued in 2026?
Based on GuruFocus' analysis, Principal Technologies stock appears to be overvalued.
The current stock price of C$0.38 is trading 1166.7% above its estimated GF Value™ of C$0.03.
GuruFocus considers Principal Technologies to be Significantly Overvalued.
Key valuation signals for TSXV:PTEC:
EBITDA Margin %: 0.00%
GF Value™: C$0.03 vs. price of C$0.38 (1166.7% above fair value)
No single metric tells the full story. See the TSXV:PTEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Principal Technologies Inc is in the research and development stage of building a portfolio of medical technology assets with a focus on distribution potential and intellectual property capable of enhancing medical treatment, cost efficiency, and optimization of the patient pathway. The company focuses on acquiring medical technology research and development assets or developing them jointly with industry leaders. Its current revenue-generating activities are attributable to E&E CRO Consulting GmbH, which provides clinical research advisory services. The company operates in one reportable operational segment, consisting of project management of clinical studies and research related to medical device technologies.
22GF Score
Get the complete analysis for TSXV:PTEC
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:PTEC has been successfully added to your 
